Inici › Malalties pulmonars › Massachusetts › Boston
Assaigs clínics de Malalties pulmonars a Boston, MA
14 estudis de Malalties pulmonars busquen participants en centres de Boston i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
ReclutantFase 3
- Dana-Farber Cancer Institute, Boston
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
ReclutantFase 3
- Brigham and Women's Hospital, Boston
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
ReclutantFase 3
- Brigham and Women's Hospital, Boston
- Clinical Trials Center, Boston
- Clinical Trials Hub, Boston
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
ReclutantFase 2
- Brigham and Women's Hospital, Boston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
ReclutantFase 1/2
- Dana Farber Cancer Institute, Boston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutantFase 3
- Boston Medical Center, Boston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
ReclutantFase 2
- Clinical Research Site, Boston
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
ReclutantFase 2
- Beth Israel Deaconess Medical Center, Boston
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
ReclutantFase 2
- Research Site, Boston
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
ReclutantFase 2
- Dana-Farber Cancer Institute, Boston
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
ReclutantFase 1/2
- Massachusetts General Hospital,, Boston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Reclutant
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
ReclutantFase 2
- Dana-Farber Cancer Institute, Boston
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
Reclutant
- Brigham and Women's Hospital, Boston
Assaigs de Malalties pulmonars en altres ciutats
- Houston, TX15 estudis
- Durham, NC13 estudis
- New York City, NY12 estudis
- Pittsburgh, PA11 estudis
- Dallas, TX10 estudis
- Nashville, TN10 estudis
- Columbus, OH10 estudis
- Los Angeles, CA10 estudis
- Washington, DC10 estudis
- Miami, FL10 estudis
- Ann Arbor, MI10 estudis
- Chicago, IL9 estudis
Altres estudis a Boston
- Càncer de mama111 estudis
- Càncer de pulmó de cèl·lules no petites90 estudis
- Càncer (tots els tipus)86 estudis
- Càncer colorrectal63 estudis
- Càncer metastàtic63 estudis
- Càncer de pulmó62 estudis
- Càncer d'ovari61 estudis
- Càncer de pròstata59 estudis
- Depressió52 estudis
- Càncer d'endometri50 estudis
- Insuficiència cardíaca44 estudis
- Leucèmia mieloide aguda44 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.